PIERIS PHARMACEUT. DL-001 Forum: Community User: Kuhla1

Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference

Hallo zusammen! Jemand ne Idee, wie es zur Verdoppelung seit Weihnachten grkommen ist?

Guten Morgen 😁🙋‍♀️

🔥

📍

Huch kurzzeitig Raketen Männer waren auch hier 😂😂😂😂 Wenn das los geht kommt de Satz: „Keiner hat das Ding auf dem Schirm!“ 😂😂😂😂😂😂😂😂

👀

Beobachten

Läuft

Volumen ist immer noch guter Durchschnitt… spannend wird die $6 Marke… nach wie vor bemerkenswert - jeder dip wir little by little aufgefressen…

Grün: 0,18 - Vol. 1,18 Mio

Pieris Pharmaceuticals Inc.: The Winning Streak Continues (PIRS) (MENAFN - Investor Brand Network) Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) traded at a new 52-week high today of $5.82. This new high was reached on above average trading volume as 29.7 million shares traded hands, while the average 30-day volume is approximately 1.4 million shares. In the past 52 weeks, shares of Pieris Pharmaceuticals Inc. have traded between a low of $1.70 and a high of $5.82 and is now at $5.69, which is 235% above that low price. Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) is currently priced 25.9% above its average consensus analyst price target of $4.22.

Volumen: 3,76 Mio (Avrg: 3,04)

Grün: 8,99%

👀

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences Thu, September 9, 2021, 2:00 PM BOSTON,MA / ACCESSWIRE / September 9,2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences: